These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 39349693)

  • 1. Impact of Different Packaging Configurations on A Topical Cream Product.
    Mohammed YH; Namjoshi SN; Telaprolu KC; Jung N; Shewan HM; Stokes JR; Benson HAE; Grice JE; Raney SG; Rantou E; Windbergs M; Roberts MS
    Pharm Res; 2024 Oct; 41(10):2043-2056. PubMed ID: 39349693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical Semisolid Drug Product Critical Quality Attributes with Relevance to Cutaneous Bioavailability and Pharmacokinetics: Part I-Bioequivalence of Acyclovir Topical Creams.
    Mohammed YH; Namjoshi SN; Jung N; Windbergs M; Benson HAE; Grice JE; Raney SG; Roberts MS
    Pharm Res; 2024 Jul; 41(7):1507-1520. PubMed ID: 38955999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous Pharmacokinetics of Acyclovir Cream 5% Products: Evaluating Bioequivalence with an In Vitro Permeation Test and an Adaptation of Scaled Average Bioequivalence.
    Shin SH; Rantou E; Raney SG; Ghosh P; Hassan H; Stinchcomb A
    Pharm Res; 2020 Oct; 37(10):210. PubMed ID: 33001286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of performance matrix for generic product equivalence of acyclovir topical creams.
    Krishnaiah YS; Xu X; Rahman Z; Yang Y; Katragadda U; Lionberger R; Peters JR; Uhl K; Khan MA
    Int J Pharm; 2014 Nov; 475(1-2):110-22. PubMed ID: 25089511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of an Optimized Tape Stripping Method for the Bioequivalence Assessment of Topical Acyclovir Creams.
    Nallagundla S; Patnala S; Kanfer I
    AAPS PharmSciTech; 2018 May; 19(4):1567-1573. PubMed ID: 29484615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection.
    Hasler-Nguyen N; Shelton D; Ponard G; Bader M; Schaffrik M; Mallefet P
    BMC Dermatol; 2009 Apr; 9():3. PubMed ID: 19341466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open Flow Microperfusion as a Dermal Pharmacokinetic Approach to Evaluate Topical Bioequivalence.
    Bodenlenz M; Tiffner KI; Raml R; Augustin T; Dragatin C; Birngruber T; Schimek D; Schwagerle G; Pieber TR; Raney SG; Kanfer I; Sinner F
    Clin Pharmacokinet; 2017 Jan; 56(1):91-98. PubMed ID: 27539717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stratum Corneum Sampling to Assess Bioequivalence between Topical Acyclovir Products.
    Pensado A; Chiu WS; Cordery SF; Rantou E; Bunge AL; Delgado-Charro MB; Guy RH
    Pharm Res; 2019 Nov; 36(12):180. PubMed ID: 31728737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical delivery of acyclovir and ketoconazole.
    Jacobs GA; Gerber M; Malan MM; du Preez JL; Fox LT; du Plessis J
    Drug Deliv; 2016; 23(2):631-41. PubMed ID: 25005585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detailed pharmacokinetic characterization of advanced topical acyclovir formulations with IVPT and in vivo Open Flow Microperfusion.
    Schwagerle G; Sharp MJ; Parr A; Schimek D; Mautner SI; Birngruber T
    Int J Pharm; 2023 Aug; 643():123269. PubMed ID: 37495025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of in vitro Skin Permeation of Clascoterone From Clascoterone Topical Cream, 1% (w/w).
    Yang Y; Wang J; Wanasathop A; Niu M; Ghosh P; Zidan A; Gu J; Hunt R; Faustino P; Ashraf M; Xu X
    AAPS PharmSciTech; 2024 Aug; 25(6):186. PubMed ID: 39138712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of critical formulation parameters affecting the in vitro release, permeation, and rheological properties of the acyclovir topical cream.
    Kamal NS; Krishnaiah YSR; Xu X; Zidan AS; Raney S; Cruz CN; Ashraf M
    Int J Pharm; 2020 Nov; 590():119914. PubMed ID: 32979451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheological and
    Miron DS; Rădulescu FȘ; Voicu VA; Mînea A; Cardot JM; Shah VP
    Pharm Dev Technol; 2021 Sep; 26(7):779-787. PubMed ID: 34165370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Permeation Test (IVPT) for Pharmacokinetic Assessment of Topical Dermatological Formulations.
    Santos LL; Swofford NJ; Santiago BG
    Curr Protoc Pharmacol; 2020 Dec; 91(1):e79. PubMed ID: 32991075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microemulsion-based hydrogel formulation of penciclovir for topical delivery.
    Zhu W; Guo C; Yu A; Gao Y; Cao F; Zhai G
    Int J Pharm; 2009 Aug; 378(1-2):152-8. PubMed ID: 19463929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro studies into establishing therapeutic bioequivalence of complex topical products: Weight of evidence.
    Miranda M; Volmer Z; Cornick A; Goody A; Cardoso C; Pais AACC; Brown M; Vitorino C
    Int J Pharm; 2024 May; 656():124012. PubMed ID: 38537923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstructed Human Epidermis: An Alternative Approach for In Vitro Bioequivalence Testing of Topical Products.
    Agonia AS; Palmeira-de-Oliveira A; Cardoso C; Augusto C; Pellevoisin C; Videau C; Dinis-Oliveira RJ; Palmeira-de-Oliveira R
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 35893811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical quality attributes, in vitro release and correlated in vitro skin permeation-in vivo tape stripping collective data for demonstrating therapeutic (non)equivalence of topical semisolids: A case study of "ready-to-use" vehicles.
    Ilić T; Pantelić I; Lunter D; Đorđević S; Marković B; Ranković D; Daniels R; Savić S
    Int J Pharm; 2017 Aug; 528(1-2):253-267. PubMed ID: 28602800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical Semisolid Products-Understanding the Impact of Metamorphosis on Skin Penetration and Physicochemical Properties.
    Jin X; Imran M; Mohammed Y
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of uptake and clearance of acyclovir in skin layers.
    Nair AB
    Antivir Ther; 2016; 21(1):17-25. PubMed ID: 26046929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.